Ir al contenido principal

22-431 Offer Patients Added Treatment Options for COVID-19 with Oral Antivirals

June 10, 2022

This information applies to Physicians and Independent Practice Associations.

PaxlovidTM and LagevrioTM – authorized for emergency use by the U.S. Food and Drug Administration – can be prescribed to treat mild to moderate COVID-19 for use at home.

This flyer shares information about two COVID-19 oral antiviral medications – PaxlovidTM and LagevrioTM. These are available by prescription only to individuals who qualify, have mild to moderate COVID-19 symptoms and who are at high risk.

Download the provider updateEste documento PDF se abrirá en una ventana nueva.

Ícono de contacto

¿Necesita ayuda? Puede contar con nosotros.

Contáctenos
Last Updated On: 8/12/2024
El 21 de febrero de 2024, Change Healthcare sufrió un incidente de ciberseguridad. Toda persona afectada por este incidente recibirá una carta por correo. Obtenga más información sobre este incidente de Change Healthcare o comuníquese con el centro de contacto al 1-866-262-5342. x